FI971277A0 - Kompositioner innehållande åtminstone en glukocorticosteroid i kombination med ett lungytaktivt ämne för behandling av IRDS och ARDS - Google Patents

Kompositioner innehållande åtminstone en glukocorticosteroid i kombination med ett lungytaktivt ämne för behandling av IRDS och ARDS

Info

Publication number
FI971277A0
FI971277A0 FI971277A FI971277A FI971277A0 FI 971277 A0 FI971277 A0 FI 971277A0 FI 971277 A FI971277 A FI 971277A FI 971277 A FI971277 A FI 971277A FI 971277 A0 FI971277 A0 FI 971277A0
Authority
FI
Finland
Prior art keywords
compositions
treatment
irds
glucocorticosteroid
ards
Prior art date
Application number
FI971277A
Other languages
English (en)
Finnish (fi)
Other versions
FI971277A (sv
FI118886B (sv
Inventor
Paul-Georg Germann
Klaus Eistetter
Ulrich Kilian
Dietrich Haefner
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of FI971277A0 publication Critical patent/FI971277A0/sv
Publication of FI971277A publication Critical patent/FI971277A/sv
Application granted granted Critical
Publication of FI118886B publication Critical patent/FI118886B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
FI971277A 1994-09-28 1997-03-26 Användning av en kombination av ett ytaktivitetsmedel för lungorna och minst en glukokortikosteroid för framställning av ett läkemedel avsett för vård av IRDS och ARDS FI118886B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4434629 1994-09-28
DE4434629A DE4434629C1 (de) 1994-09-28 1994-09-28 Zusammensetzungen zur Behandlung von IRDS und ARDS
PCT/EP1995/003816 WO1996009831A2 (de) 1994-09-28 1995-09-27 Zusammensetzungen zur behandlung von irds und ards, die mindestens ein glucocorticosteroid in kombination mit einem lungen surfactant enthalten
EP9503816 1995-09-27

Publications (3)

Publication Number Publication Date
FI971277A0 true FI971277A0 (sv) 1997-03-26
FI971277A FI971277A (sv) 1997-05-27
FI118886B FI118886B (sv) 2008-04-30

Family

ID=6529394

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971277A FI118886B (sv) 1994-09-28 1997-03-26 Användning av en kombination av ett ytaktivitetsmedel för lungorna och minst en glukokortikosteroid för framställning av ett läkemedel avsett för vård av IRDS och ARDS

Country Status (26)

Country Link
US (1) US5891844A (sv)
EP (1) EP0783314B1 (sv)
JP (1) JP4425991B2 (sv)
KR (1) KR100365030B1 (sv)
CN (1) CN1100542C (sv)
AT (1) ATE241372T1 (sv)
AU (1) AU705099B2 (sv)
BG (1) BG62556B1 (sv)
CA (1) CA2201377C (sv)
CZ (1) CZ292846B6 (sv)
DE (2) DE4434629C1 (sv)
DK (1) DK0783314T3 (sv)
EE (1) EE03422B1 (sv)
ES (1) ES2201120T3 (sv)
FI (1) FI118886B (sv)
HK (1) HK1003869A1 (sv)
HU (1) HU226958B1 (sv)
MX (1) MX9702303A (sv)
NO (1) NO313405B1 (sv)
NZ (1) NZ294587A (sv)
PL (1) PL187496B1 (sv)
PT (1) PT783314E (sv)
RU (1) RU2157222C2 (sv)
SK (1) SK284446B6 (sv)
UA (1) UA43378C2 (sv)
WO (1) WO1996009831A2 (sv)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
CA2276429C (en) * 1997-02-17 2007-06-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant
US7122344B2 (en) 1997-05-28 2006-10-17 Claragen, Inc. Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
US20060281681A1 (en) 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US20020017295A1 (en) * 2000-07-07 2002-02-14 Weers Jeffry G. Phospholipid-based powders for inhalation
US6946117B1 (en) * 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6433040B1 (en) * 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
CN1194833A (zh) * 1997-10-08 1998-10-07 刘柏宏 肺活素
US6858223B2 (en) 1998-06-23 2005-02-22 Altana Pharma Ag Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS)
AU5400000A (en) * 1999-06-11 2001-01-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c)
EP1216052A1 (en) * 1999-09-16 2002-06-26 Byk Gulden Lomberg Chemische Fabrik GmbH Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
DE19957898A1 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant
DE10018022A1 (de) * 2000-04-12 2001-10-31 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant zur Prophylaxe oder Frühbehandlung von akuten Lungenerkrankungen
CA2405811C (en) * 2000-04-12 2011-09-27 Altana Pharma Ag Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases
US20040254112A1 (en) * 2000-04-12 2004-12-16 Dietrich Hafner Use of pulmonary surfactant for the early treatment of acute pulmonary diseases
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
TWI290473B (en) * 2000-05-10 2007-12-01 Alliance Pharma Phospholipid-based powders for drug delivery
DE10132307A1 (de) * 2001-07-06 2003-01-30 Aventis Behring Gmbh Arzneizubereitung zur Inhalation von Antithrombin bei entzündlichen Lungenerkrankungen und ARDS
US20030099601A1 (en) * 2001-11-27 2003-05-29 Gordon Marc S. Inhalation lung surfactant therapy
US6998384B2 (en) * 2001-12-12 2006-02-14 The Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
ATE508735T1 (de) 2001-12-19 2011-05-15 Novartis Ag Pulmonale verabreichung von aminoglykosiden
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
CA2529007C (en) 2003-06-16 2012-03-27 Altana Pharma Ag Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases
PL1670482T5 (pl) * 2003-09-16 2022-10-03 Covis Pharma Gmbh Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
PT1841458E (pt) 2005-01-06 2012-04-10 Discovery Lab Inc Regime de tratamento com surfactante para tratar ou prevenir displasia broncopulmonar
KR100891595B1 (ko) 2005-02-28 2009-04-03 주식회사 케이티앤지 혈액 단백질의 삼출을 감소시키는 조성물
AU2007297691B2 (en) * 2006-09-19 2013-12-19 Discovery Laboratories, Inc. Pulmonary surfactant formulations and methods for promoting mucus clearance
EP2022798A1 (en) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides
US9345716B2 (en) * 2010-12-10 2016-05-24 Indian Institute Of Technology, Bombay Protein free surfactant composition for pulmonary diseases and a process for preparing the same
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation
CN106310280A (zh) * 2016-08-18 2017-01-11 滨州医学院 地瑞那韦增强糖皮质激素抗炎作用的医药新用途
BR112019012922A2 (pt) * 2016-12-22 2019-12-10 Chiesi Farm Spa combinação de um surfactante pulmonar, uso de uma combinação de um surfactante pulmonar e kit

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4944941A (en) * 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances

Also Published As

Publication number Publication date
US5891844A (en) 1999-04-06
RU2157222C2 (ru) 2000-10-10
AU3742895A (en) 1996-04-19
NO971403D0 (no) 1997-03-25
AU705099B2 (en) 1999-05-13
EP0783314B1 (de) 2003-05-28
WO1996009831A2 (de) 1996-04-04
FI971277A (sv) 1997-05-27
CN1100542C (zh) 2003-02-05
KR970706006A (ko) 1997-11-03
DE59510705D1 (de) 2003-07-03
JP4425991B2 (ja) 2010-03-03
EE03422B1 (et) 2001-06-15
ATE241372T1 (de) 2003-06-15
JPH10506119A (ja) 1998-06-16
WO1996009831A3 (de) 1996-05-23
NO971403L (no) 1997-04-17
SK284446B6 (sk) 2005-04-01
PL187496B1 (pl) 2004-07-30
FI118886B (sv) 2008-04-30
HUT77931A (hu) 1998-11-30
CZ94097A3 (en) 1997-09-17
BG101441A (en) 1997-09-30
HU226958B1 (en) 2010-03-29
EE9700084A (et) 1997-10-15
SK40197A3 (en) 1998-02-04
PL319608A1 (en) 1997-08-18
EP0783314A2 (de) 1997-07-16
CN1163571A (zh) 1997-10-29
CZ292846B6 (cs) 2003-12-17
PT783314E (pt) 2003-10-31
CA2201377C (en) 2008-07-29
HK1003869A1 (en) 1998-11-13
NZ294587A (en) 1998-07-28
UA43378C2 (uk) 2001-12-17
ES2201120T3 (es) 2004-03-16
KR100365030B1 (ko) 2003-03-10
DK0783314T3 (da) 2003-12-01
DE4434629C1 (de) 1996-06-27
BG62556B1 (bg) 2000-02-29
MX9702303A (es) 1997-06-28
NO313405B1 (no) 2002-09-30
CA2201377A1 (en) 1996-04-04

Similar Documents

Publication Publication Date Title
FI971277A0 (sv) Kompositioner innehållande åtminstone en glukocorticosteroid i kombination med ett lungytaktivt ämne för behandling av IRDS och ARDS
FI910393A0 (fi) Semi-termoplastisk matriskomposition med vaermestabilt formbestaendigt minne.
FI893127A0 (fi) Komposition som bildar en vattenavstoetande film.
MY109880A (en) Substituted biphenylpyridones
IT8522521A0 (it) Lavoro, con porzioni separate. sedia, in particolare sedia da
NO892217D0 (no) Manoevreringsanordning for lasteskuffe.
DE68920444D1 (de) Kurzfasern und elastomere, verstärkte zusammensetzung mit kurzfasern.
DE69324015T2 (de) Verbesserungen in, oder in verbindung mit keimtötenden zusammensetzungen
ATE210149T1 (de) Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
DE69006878D1 (de) Teilchenförmiger Reinigungsmittel-Zusatz, dessen Herstellung und Verwendung in Reinigungsmittelzusammensetzungen.
DE69003706T2 (de) UV-vernetzbare, anpassungsfähige Beschichtung mit Doppelaushärtung in den Schattengebieten.
DE69001295D1 (de) In zufuhranlage niederschlaege kontrollierende zusammensetzungen.
DE68902882T2 (de) Synergische additivzusammensetzung, verwendbar in kraftuebertragungszusammensetzungen.
ES2132145T3 (es) Preparado con accion acaricida.
IT8323898V0 (it) Apparecchio frigorifero combinato, in particolare mobile frigorifero per uso domestico, con porta in comune per un reparto frigorifero normale e per un reparto congelatore disposti uno sopra l'altro.
DE69112642D1 (de) Glutaminhaltige lyophilisierte aminokarbonsäurenzusammensetzungen.
IT8822296A0 (it) Composizione di combustibile ad elevato contenuto energetico.
SU848767A1 (ru) Эжектор
NO894777D0 (no) Stoppemekanisme med lav manoevreringskraft for baneutlevering.
IT7809537V0 (it) Giunto perfezionato, in particolare per scaffalature, mobili e consimili.
NO885009D0 (no) Anordning ved luftinntak i respirator.
NO913270D0 (no) Opplagring for mellomaksel med dobbelt universalledd ved hvert endeparti.
ES1017205Y (es) Perfeccionamientos en los elementos sustentadores para sillas, sillones y similares.
IT241784Y1 (it) Camicia con imbottitura disposta in corrispondenza delle spalle.
IT8224930A0 (it) Composizione detergente e disinfettante ad ossigeno attivo.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NYCOMED GMBH

Free format text: NYCOMED GMBH

FG Patent granted

Ref document number: 118886

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: TAKEDA GMBH

MM Patent lapsed